Penn Medicine Provider
Dermatology
Katherine Thacker Steele, MD
5.0
(361)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineSchedule online

About me

  • Assistant Professor of Clinical Dermatology

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

361 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

March 2025
5.0
5.0
she listened to my concerns.
March 2025
5.0
5.0
professional, punctual and polite
March 2025
5.0
5.0
i would not hesitate to recommend dr steele to family and friends.
March 2025
5.0
5.0
she's the best

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Steele is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Yoon IC, Do N, Vazquez T, Elder D, Steele KT, Rosenbach M. Injection site reaction to teclistamab in a patient with multiple myeloma , JAAD Case Reports: 2024

Milbar HC, Caplan AS, Schwab RD, Coromilas AJ, Baumrin E, Forrestel A, Steele KT, Micheletti RG, Perl AE, Rosenbach M Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature , Blood Adv, 7(19): 2023,5780-83

Wei J, Wachuku C, Berk-Krauss J, Steele KT, Rosenbach M, Messenger E Severe cutaneous ulcerations secondary to xylazine (tranq): A case series , JAAD Case Rep, 36: 2023,89-91

Godse R, Rauck C, Woods R, Steele KT, Elenitsas R. Two Cases of Insulin-Derived Amyloidosis With Acanthosis Nigricans-Like Changes , Am J Dermatopathol: 2022

Bhattacharya S, Basu S, Sheng E, Murphy CM, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele KT, Forrestel AK, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH. Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome. , J Clin Invest: 2022

Alam M, Lewis W, Harp J, Steele K, Rosenbach M, Micheletti RG Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic , Cutis, 107(4): 2021,209-15

Steele KT, Markova A. Cutaneous adverse events of molecularly targeted therapy and other biologic agents used for cancer therapy , Drews RE, ed. UpToDate. Waltham, MA: UpToDate, Inc.: 2021

Stephens MR, Aderibigbe O, Steele KT, Elder DE, Glaser L, Jacob J, Rosenbach M. Draining dorsal hand pustules, nodules, and ulcers in a patient with immunosuppression , JAAD Case Reports, 5(10): 2019,846-848

Buter J, Steele KT, Chung KC, Elzinga K. Extravasation injury from chemotherapy and other non-antineoplastic vesicants , Drews RE, ed. UpToDate. Waltham, MA: UpToDate, Inc. Published online: 2019

Steele KT, Miller CJ “Melanoma in situ.” In: Alam, Murad (Ed.) Evidence-Based Procedural Dermatology, 2nd Edition , 2nd Edition. Springer: 2019